Clinical trial
Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the…
NCT00166894 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00166894 |
|---|---|
| Title | Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion |
| Official title | Evaluation of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a Diagnostic Tool for Patients With Pleural Effusion |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Pleural Effusion |
| Enrollment | 100 |
| Start date | May 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 24, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: